Bicoll logo — We envision molecules for epilepsy and longevity: 

Research...

Bicoll

We envision molecules for epilepsy and longevity: Research and development of novel patentable structures.

Founded 2000 Germany Germany 13 employees Grant Total: $23.60M Agriculture, Biotechnology +1

General Information

Company Name Bicoll
Founded Year 2000
Location Germany Germany
Employees 13
Industries Agriculture, Biotechnology, Pharmaceutical
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Bicoll. To contact Bicoll, visit bicoll-group.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Bicoll

Bicoll, We envision molecules for epilepsy and longevity: Research and development of novel patentable structures. Founded in 2000 and headquartered in Germany, Bicoll specializes in bioactive plant-derived small molecules, leveraging its expertise in high-tech natural product chemistry and medicinal chemistry. The company's primary focus lies in neurodegenerative disorders (specifically epilepsy) and longevity, with an emphasis on developing proprietary preclinical candidates in these fields. The latest investment in Bicoll, a €1.80M grant, was received on 15 July 2019. The investor information for this round is currently unavailable. Bicoll operates within the agriculture, biotechnology, and pharmaceutical industries, showcasing a diverse set of applications for its innovative molecules.

Taxonomy: Drug Discovery, Medicinal Chemistry, Natural Products, Plant-based Compounds, Neurodegenerative Disorders, Epilepsy, Longevity, Pharmaceuticals, Cosmetics, Nutraceuticals, Research and Development, Bioactive Molecules, Innovation

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €1.80M -
15 Jul 2019
Grant €1.60M -
17 Nov 2017
Grant €1.00M -
12 Mar 2014
Grant €11.50M -
29 Oct 2013
Grant €1.00M -
20 Jul 2011
Grant €3.00M -
22 Feb 2010
Grant €3.20M -
03 Jul 2007
Grant €500.00K -
12 Dec 2000

Bicoll Alternatives & Competitors

Bicoll vs

Advancing Human Health with Pioneering Chemistry. Committed to Innovation, Quality, and Your R&D Suc...

45 employees
Biotechnology, Life Sciences
Bicoll vs

We aspire to be a world class innovative drug discovery company from China.

37 employees
Biotechnology, Pharmaceutical
Bicoll vs
EOLO PHARMA
EOLO PHARMA United States

Cutting-Edge Pharmacological Treatment for Obesity

Venture round
12 employees
Biopharma, Biotechnology

FAQ About Bicoll

We envision molecules for epilepsy and longevity: Research and development of novel patentable structures.
Bicoll was founded in 2000.
Bicoll is headquartered in Germany.
Bicoll operates in Agriculture, Biotechnology and Pharmaceutical. Its work centres on Drug Discovery, Medicinal Chemistry, Natural Products and Plant-based Compounds.
Bicoll has approximately 13 employees.
Bicoll has completed 8 funding rounds, raising a total of $23.60M. The latest funding stage is Grant.
Top alternatives and competitors to Bicoll include Taros Discovery, Regor Therapeutics Group, EOLO PHARMA, Pharvaris, 1200 Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bicoll and Taros Discovery are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Bicoll, https://bouncewatch.com/company/bicoll, updated 11 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes